NO932547L - Isoksazolederivater for behandling av irritabelt tarmsyndrom - Google Patents

Isoksazolederivater for behandling av irritabelt tarmsyndrom

Info

Publication number
NO932547L
NO932547L NO932547A NO932547A NO932547L NO 932547 L NO932547 L NO 932547L NO 932547 A NO932547 A NO 932547A NO 932547 A NO932547 A NO 932547A NO 932547 L NO932547 L NO 932547L
Authority
NO
Norway
Prior art keywords
bowel syndrome
irritable bowel
treatment
isoxazole derivatives
isoxazole
Prior art date
Application number
NO932547A
Other languages
English (en)
Other versions
NO932547D0 (no
NO304054B1 (no
Inventor
Jaswant Singh Gidda
John Mehnert Schaus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO932547D0 publication Critical patent/NO932547D0/no
Publication of NO932547L publication Critical patent/NO932547L/no
Publication of NO304054B1 publication Critical patent/NO304054B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO932547A 1992-07-17 1993-07-13 Anvendelse av isoxazolederivater for fremstilling av et medikament for behandling av irritable tarmsyndrom NO304054B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91628192A 1992-07-17 1992-07-17

Publications (3)

Publication Number Publication Date
NO932547D0 NO932547D0 (no) 1993-07-13
NO932547L true NO932547L (no) 1994-01-18
NO304054B1 NO304054B1 (no) 1998-10-19

Family

ID=25436992

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932547A NO304054B1 (no) 1992-07-17 1993-07-13 Anvendelse av isoxazolederivater for fremstilling av et medikament for behandling av irritable tarmsyndrom

Country Status (23)

Country Link
US (1) US5434174A (no)
EP (1) EP0579507B1 (no)
JP (1) JPH06166620A (no)
CN (1) CN1049336C (no)
AT (1) ATE206918T1 (no)
AU (1) AU666377B2 (no)
CA (1) CA2100399A1 (no)
CZ (1) CZ284881B6 (no)
DE (1) DE69330926T2 (no)
DK (1) DK0579507T3 (no)
ES (1) ES2162808T3 (no)
HK (1) HK1013795A1 (no)
HU (1) HUT68727A (no)
IL (1) IL106307A (no)
MX (1) MX9304205A (no)
NO (1) NO304054B1 (no)
PH (1) PH30148A (no)
PL (1) PL172494B1 (no)
PT (1) PT579507E (no)
RU (1) RU2127111C1 (no)
TW (1) TW232653B (no)
UA (1) UA27720C2 (no)
ZA (1) ZA934969B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
US6362371B1 (en) * 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
FR2792529B1 (fr) * 1999-04-26 2001-09-28 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
UA76130C2 (en) * 2000-11-20 2006-07-17 Merck Patent Gmbh Use of compounds combining properties of selective inhibitors of serotonin re-uptake and agonists of 5-ht1a receptor for treatment of irritable bowel syndrome
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
PL378367A1 (pl) * 2003-01-13 2006-04-03 Dynogen Pharmaceuticals, Inc. Sposób leczenia czynnościowych zaburzeń jelit
SE0301798D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use IV
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
SE0301794D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US7684402B2 (en) 2006-05-15 2010-03-23 Faraday Technology Corp. Method and network device for fast look-up in a connection-oriented communication
WO2014105655A1 (en) 2012-12-24 2014-07-03 Neurogastrx, Inc. Methods for treating gi tract disorders
US9844554B2 (en) 2014-06-24 2017-12-19 Neurogastrx, Inc. Prodrugs of metopimazine
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT90366A (pt) * 1988-04-28 1989-11-10 Beecham Group Plc Processo para a producao de compostos glicopeptidicos
AU654653B2 (en) * 1989-05-31 1994-11-17 Pharmacia & Upjohn Company Therapeutically useful 2-aminotetralin derivatives
SE8904361D0 (sv) * 1989-12-22 1989-12-22 Astra Ab New chroman and thiochroman derivatives
US5158956A (en) * 1990-05-04 1992-10-27 Eli Lilly And Company Method of inhibiting gastric acid secretion with benzodioxanes
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
DE69218813T2 (de) * 1991-02-08 1997-08-14 Lilly Co Eli Ringsubstituierte 2-Amino-1,2,3,4-tetrahydronaphthaline

Also Published As

Publication number Publication date
ATE206918T1 (de) 2001-11-15
ZA934969B (en) 1995-01-09
US5434174A (en) 1995-07-18
CZ137193A3 (en) 1994-11-16
AU4199393A (en) 1994-01-20
CN1111986A (zh) 1995-11-22
ES2162808T3 (es) 2002-01-16
PL172494B1 (pl) 1997-09-30
CZ284881B6 (cs) 1999-03-17
IL106307A (en) 1997-06-10
HK1013795A1 (en) 1999-09-10
IL106307A0 (en) 1993-11-15
DE69330926T2 (de) 2002-04-11
HU9302035D0 (en) 1993-10-28
HUT68727A (en) 1995-07-28
DK0579507T3 (da) 2001-11-12
NO932547D0 (no) 1993-07-13
DE69330926D1 (de) 2001-11-22
PH30148A (en) 1997-01-21
CA2100399A1 (en) 1994-01-18
EP0579507B1 (en) 2001-10-17
PT579507E (pt) 2002-02-28
MX9304205A (es) 1995-01-31
JPH06166620A (ja) 1994-06-14
UA27720C2 (uk) 2000-10-16
TW232653B (no) 1994-10-21
CN1049336C (zh) 2000-02-16
RU2127111C1 (ru) 1999-03-10
EP0579507A1 (en) 1994-01-19
PL299690A1 (en) 1994-03-21
NO304054B1 (no) 1998-10-19
AU666377B2 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
NO932547L (no) Isoksazolederivater for behandling av irritabelt tarmsyndrom
NO905156D0 (no) Fremgangsmaate for behandling av borekaks under olje- og gassboring.
NO871493L (no) Fremgangsmaate og apparat for undersoekelse av en grunnformasjon som gjennomtrenges av et borehull.
DE3750355T2 (de) 23-Oxo(keto) und 23-Imino-Derivate von LL-F28249-Verbindungen.
IT1282628B1 (it) Processo per la preparazione di perfluoropolieteri perossidici
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
NO912548L (no) Fremgangsmaate for behandling av avfallsprodukter.
AR246162A1 (es) Composicion antimicrobiana
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
NO903338D0 (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
FI890864A (fi) Anvaendning av 1,4-dihydropyridinderivat.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
NO864272L (no) Fremgangsmaate og anordning for haandtering av boreroer.
NO890630D0 (no) Fremgangsmaate for behandling av aluminiumholdig avfall.
NO922635L (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
DE69117943T2 (de) Behandlung von tieren
NO902968D0 (no) Fremgangsmaate for behandling av boreslam.
DK130293D0 (da) Benzox(thi)azine derivatives, pharmaceutical compositions thereof, and method of treating therewith
NO883223L (no) Middel og fremgangsmaate for oxyderende farving av haar med3-(2',2', 2'-trifluorethyl)aminofenolderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees